Regulation of the major histocompatibility complex class I mRNA expression by bile acids in cultured human hepatoma cells. 1995

F Hirano, and H Tanaka, and Y Makino, and K Okamoto, and M Inaba, and T Miura, and I Makino
Second Department of Internal Medicine, Asahikawa Medical College, Japan.

We investigated the effect of bile acids on major histocompatibility complex (MHC) class I gene expression in the cultured human hepatoma cell HepG2. Not only chenodeoxycholic acid, but its stereoisomer ursodeoxycholic acid as well, increased steady state level of MHC class I mRNA. When various bile acids were studied, inducibility of MHC class I mRNA was closely associated with the hydrophobicity of the corresponding bile acids. Pretreatment of the cells with a protein kinase C (PKC) inhibitor H7 suppressed induction of MHC class I mRNA by those bile acids. Furthermore, treatment of the cells with chenodeoxycholic acid significantly induced translocation of PKC from cytosol to membrane. In summary, our data strongly indicate up-regulatory effect of bile acids on MHC class I mRNA expression, most probably via activation of PKC-dependent pathway.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002635 Chenodeoxycholic Acid A bile acid, usually conjugated with either glycine or taurine. It acts as a detergent to solubilize fats for intestinal absorption and is reabsorbed by the small intestine. It is used as cholagogue, a choleretic laxative, and to prevent or dissolve gallstones. Chenic Acid,Chenodeoxycholate,Chenodiol,Gallodesoxycholic Acid,Chenique Acid,Chenix,Chenofalk,Chenophalk,Henohol,Quenobilan,Quenocol,Sodium Chenodeoxycholate,Acid, Chenic,Acid, Chenique,Acid, Chenodeoxycholic,Acid, Gallodesoxycholic,Chenodeoxycholate, Sodium
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

F Hirano, and H Tanaka, and Y Makino, and K Okamoto, and M Inaba, and T Miura, and I Makino
January 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
F Hirano, and H Tanaka, and Y Makino, and K Okamoto, and M Inaba, and T Miura, and I Makino
November 1993, Immunology,
F Hirano, and H Tanaka, and Y Makino, and K Okamoto, and M Inaba, and T Miura, and I Makino
December 1992, Differentiation; research in biological diversity,
F Hirano, and H Tanaka, and Y Makino, and K Okamoto, and M Inaba, and T Miura, and I Makino
April 1990, Cancer letters,
F Hirano, and H Tanaka, and Y Makino, and K Okamoto, and M Inaba, and T Miura, and I Makino
January 1991, Cancer detection and prevention,
F Hirano, and H Tanaka, and Y Makino, and K Okamoto, and M Inaba, and T Miura, and I Makino
January 1990, Journal of reproduction and fertility. Supplement,
F Hirano, and H Tanaka, and Y Makino, and K Okamoto, and M Inaba, and T Miura, and I Makino
January 1989, The Year in immunology,
F Hirano, and H Tanaka, and Y Makino, and K Okamoto, and M Inaba, and T Miura, and I Makino
November 1991, Transplantation,
F Hirano, and H Tanaka, and Y Makino, and K Okamoto, and M Inaba, and T Miura, and I Makino
January 2011, Frontiers in immunology,
F Hirano, and H Tanaka, and Y Makino, and K Okamoto, and M Inaba, and T Miura, and I Makino
September 1994, Gastroenterology,
Copied contents to your clipboard!